Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Dedifferentiated Liposarcoma”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04668300
What this trial is testing

Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma

Who this might be right for
Metastatic AngiosarcomaMetastatic Dedifferentiated LiposarcomaMetastatic Osteosarcoma+5 more
M.D. Anderson Cancer Center 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT03307616
What this trial is testing

Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery

Who this might be right for
Dedifferentiated LiposarcomaRecurrent Dedifferentiated LiposarcomaRecurrent Undifferentiated Pleomorphic Sarcoma+3 more
M.D. Anderson Cancer Center 32
Testing effectiveness (Phase 2)Ended earlyNCT01876043
What this trial is testing

Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial

Who this might be right for
Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma
Institut Bergonié 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05886634
What this trial is testing

Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma

Who this might be right for
Dedifferentiated LiposarcomaSoft Tissue SarcomaSarcoma,Soft Tissue+4 more
Memorial Sloan Kettering Cancer Center 16